ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

SPRC SciSparc Ltd

0.93
0.00 (0.00%)
2024年6月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
SciSparc Ltd SPRC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.93 09:00:00
始値 安値 高値 終値 前日終値
0.93
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3120:17GLOBESciSparc Secures Strategic Advantage with Grant of European..
2024/4/1121:15GLOBESciSparc to Acquire AutoMax
2024/3/2121:58GLOBESciSparc: MitoCareX Unveils Groundbreaking Discovery of..
2024/3/1820:29GLOBESciSparc Granted Another Patent, Strengthening its Core..
2024/3/1421:49GLOBESciSparc Achieves Major Milestone with First Patient Dosed..
2024/3/1221:14GLOBESciSparc: MitoCareX Reveals Promising Results with Discovery..
2024/3/0823:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0821:11GLOBESciSparc Announces Enrollment of First Patient for its..
2024/3/0721:49GLOBESciSparc Granted Patent for Core Technology in Multiple..
2024/3/0714:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/3/0706:41GLOBESciSparc Issued Canadian Patent for Opioids Reduction Use in..
2024/2/2923:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2922:35GLOBESciSparc Delivers Treatment for Autism Spectrum Disorder..
2024/2/2806:15EDGAR2Form F-1 - Registration statement for certain foreign..
2024/2/2722:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2721:58GLOBEClearmind Medicine Submits Three Additional International..
2024/2/2106:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2021:14GLOBESciSparc and Clearmind Continue to Strengthen International..
2024/2/1306:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/3006:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2921:18GLOBESciSparc Announces Initiation of Patient Recruitment for its..
2024/1/2523:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2421:42GLOBESciSparc Ltd. Announces $20 Million Standby Equity Purchase..
2024/1/2220:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1923:28GLOBESciSparc Advances the Acquisition Process of a Leading..
2024/1/0421:18GLOBESciSparc and Clearmind Medicine Reflect on Successful..
2023/12/1322:18GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
2023/12/0822:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0723:05GLOBESciSparc Provides Updates Regarding the Non-Binding Letter..
2023/12/0122:14GLOBEWeight Loss Treatment: SciSparc’s Obesity Drug Showed..
2023/11/2906:55EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
2023/11/2906:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2906:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2822:55GLOBESciSparc Adopts Limited Duration Shareholder Rights Plan
2023/11/2822:25GLOBESciSparc Announces Positive Results from its Weight Loss and..
2023/11/2806:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2722:41GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
2023/11/2422:55GLOBENew Hope for Children: SciSparc's patented CBD- Enhanced..
2023/11/2306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2221:42GLOBESciSparc Signs Non-Binding Letter of Intent to Merge with..
2023/11/2106:22EDGAR2Form F-3/A - Registration statement by foreign private..
2023/11/1522:01GLOBESciSparc Celebrates Major Breakthrough: Positive Results..
2023/11/1023:10GLOBESciSparc Aims to Change Tourette Syndrome Treatments; Will..
2023/11/0405:06EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/10/3121:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/3120:38GLOBESciSparc Granted Patent from the Australian Patent Office..
2023/10/2420:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2420:20GLOBESciSparc Granted Patent for its Core Technology From the..
2023/10/1819:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1706:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock